搜索结果: 76-90 共查到“知识库 肿瘤诊断学”相关记录822条 . 查询时间(1.633 秒)
探讨生长相关癌基因产物β（growth-related gene product β ，GRO β）用于结直肠癌诊断潜在的可能性。方法：收集123 例结直肠癌、88例健康对照及125 例非肿瘤患者外周血清，ELISA 法分析GRO β 的含量；免疫发光法分析CEA 及CA19- 9 的含量。统计分析不同临床特征结直癌之间GRO β 的差异；ROC 曲线评估GRO β 、CEA 和CA19- 9 诊...
螺旋断层放疗提升鼻咽癌放疗剂量的可行性研究
螺旋断层放疗 调强放疗 处方剂量 鼻咽癌
<
2016/4/1
探讨应用螺旋断层放疗(HT)进行鼻咽癌放疗处方剂量提升的可行性及剂量学特点。方法 选取10例9野静态调强放疗的鼻咽癌计划,制定HT计划和静态调强(sIMRT)计划。在危及器官(OAR)符合正常组织临床影响量化分析标准的前提下,提升两组计划处方剂量,并比较剂量提升空间及处方剂量提升后两者的剂量学差异。结果 与sIMRT计划相比,HT计划所达到的处方剂量比sIMRT计划增加了42.6%(t=6.373...
An Organizational Informatics Analysis of Colorectal, Breast, and Cervical Cancer Screening Clinical Decision Support and Information Systems within Community Health Centers
community health centers clinical decision support network analysis
<
2015/5/26
A study design has been developed that employs a dual modeling approach to identify factors associated with facility-level cancer screening improvement and how this is mediated by the use of clinical ...
Carcinoma of unknown primary–rare but ripe for help from genomics?
Carcinoma genomics cancer
<
2015/4/21
The treatment of most cancer patients is based on first determining where the cancer arose anatomically – lung, breast, prostate and so on. For a group of patients with disseminated disease, this cruc...
Is genomics making rare cancers common and common cancers rare?
genomics rare cancers tumour
<
2015/4/21
While rare cancers account for a large percentage of total cancer cases, there has been little improvement in the overall survival rates for patients with rare cancers. This can partially be attribute...
Rare molecular subsets among lung tumours–what makes them stand apart from the common?
Rare molecular subsets tumours cancers
<
2015/4/21
While there is no universally agreed upon definition, rare malignancies are often defined as those with an incidence of <6 per l00,000 population. However, increasingly, commonly occurring cancers are...
Molecular insights influencing the management of head and neck cancers
Molecular insights head and neck cancers
<
2015/4/21
Head and neck cancers represent a clinically diverse group of tumours with distinctive molecular features. Understanding the importance of characteristic molecular changes has permitted the definition...
Brain tumours: Successes and challenges on the other side of the blood-brain barrier
Brain tumours the blood-brain barrier cancers
<
2015/4/21
Tumours of the central nervous system encompass a large variety of cancers, ranging from slow-growing to rapidly progressive. Although comparatively rare in adults, central nervous system malignancies...
Over half of all gynaecologic cancers are rare: barriers and challenges to improving outcomes
gynaecologic cancers treatment
<
2015/4/21
available evidence from randomised controlled trials to guide management for an individual patient. Over 50% of gynaecological cancers are classified as ‘rare’, which creates additional challenges in ...
Rare urogenital tumours likely to be encountered by oncologists include testicular cancer, non-urothelial tumours of the bladder and urethral and penile cancers. Testicular cancer is a rare but highly...
Neuroendocrine tumours–models for rare tumour management
Neuroendocrine tumours rare tumour management
<
2015/4/21
Neuroendocrine tumours have posed a challenge for the development of research and management strategies because of their rarity and heterogeneity, both from clinical and molecular perspectives. Classi...
Advances in our understanding and management of sarcomas–rare bone and soft tissue cancers
sarcomas rare bone and soft tissue cancers
<
2015/4/21
Bone and soft tissue sarcomas are rare, accounting for approximately 1% of all adult solid malignant tumors. Although these cancers are categorised under the same banner of ‘sarcoma’, they in fact rep...
Rare haematologic malignancies: bad diseases can have great outcomes when the right treatments are discovered
Rare haematologic malignancies bad diseases treatments
<
2015/4/21
Individual haematologic malignancies are uncommon when compared to solid tumours. Careful definition of distinct subtypes of leukaemias and lymphomas by marrying clinical characteristics with distinct...
Rare Cancers: how far have we come and where should we be heading? Extending evidence-based care to people with rare cancers
rare cancers cancer types patients
<
2015/4/21
Approximately one third of Australians who die of cancer do so from one classified as being ‘rare’. While there have been significant recent improvements seen for many patients with common cancer type...